Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...

Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

A leading expert has told how early-onset dementia sees you lose your connection to the rest of the world and explains the ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

A nutritionist has sounded the alarm after research revealed that millions of Brits are not getting enough of a crucial ...